Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DXCM
DXCM logo

DXCM News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

DXCM News

Omnipod 5 Insulin Delivery System Launches in Spain

1d agoYahoo Finance

Investigation into DexCom Shareholder Rights

4d agoPRnewswire

Two Stocks Wall Street Loves and One to Sell

5d agoYahoo Finance

Deutsche Bank Initiates Buy Ratings for Insulet and DexCom Amid Market Recovery

Jun 23 2026seekingalpha

Dexcom Launches Pediatric Stelo and New App Experience

Jun 23 2026Newsfilter

Major Rating Changes on Wall Street

Jun 23 2026CNBC

Abbott's Q2 Earnings Preview and Growth Drivers

Jun 20 2026Fool

Abbott's Diversified Business Fuels Growth

Jun 20 2026NASDAQ.COM

DXCM Events

06/23 09:30
DexCom Launches Stelo Glucose Sensor and App
DexCom announced at Aspen Ideas: Health a series of milestones that advance its vision of making glucose biosensing more accessible. The company announced pediatric clearance for the Stelo Glucose Biosensor and the launch of its fully reimagined Stelo app experience in July for Apple iPhone and Android users in the United States. "Glucose matters for everyone and better understanding it can help prevent serious health complications," said Jake Leach, president and CEO of Dexcom. "That's why we're working to expand access to glucose biosensing to make preventive, personalized care a reality and making our Stelo app experience more approachable with real-time insights that help people act earlier, before disease takes hold."

DXCM Monitor News

Dexcom Inc hits a 20-day low amid market weakness

Jun 22 2026

Dexcom Reports Positive CONNECT Trial Results at ADA Conference

Jun 08 2026

Dexcom Expands Partnership with Signos Amid Funding Round

Jun 01 2026

Dexcom Launches New Continuous Glucose Monitoring System

May 20 2026

Dexcom Launches New Continuous Glucose Monitoring System

May 19 2026

Dexcom Launches New Continuous Glucose Monitoring System

May 18 2026

Dexcom Inc stock rises despite broader market decline

May 15 2026

Dexcom Positioned to Benefit from Weight-Loss Drug Market Growth

Apr 29 2026

DXCM Earnings Analysis

Driving Innovation with Strategic Growth - Intellectia AI™
1 years ago
Dexcom Inc Reports Third Quarter 2024 Financial Results
1 years ago

People Also Watch